The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns

被引：35
|
作者：
Cuende, Natividad [1 ]
Boniface, Christelle [2 ]
Bravery, Christopher [3 ]
Forte, Miguel [2 ]
Giordano, Rosaria [4 ]
Hildebrandt, Martin [5 ]
Izeta, Ander [6 ]
Dominici, Massimo [7 ]
机构：
[1] Junta Andalucia, Serv Andaluz Salud, Andalusian Initiat Adv Therapies, Seville, Spain
[2] TxCell SA, Valbonne, Sophia Antipoli, France
[3] Consulting Adv Biol Ltd, London, England
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[5] Tech Univ Munich, TUMCells Interdisciplinary Ctr Cellular Therapie, D-80290 Munich, Germany
[6] Hosp Univ Donostia, Inst Biodonostia, Tissue Engn Lab, San Sebastian, Spain
[7] Univ Hosp Modena & Reggio Emilia, Lab Cell Biol & Adv Canc Therapies, Modena, Italy
来源：
CYTOTHERAPY | 2014年 / 16卷 / 12期
关键词：
MARROW MONONUCLEAR-CELLS;
D O I：
10.1016/j.jcyt.2014.08.007
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1597 / 1600
页数：4
相关论文
共 50 条
  • [1] Hospital Exemption for Advanced Therapy Medicinal Products: Issue in Application in the European Union Member States
    Ivaskiene, Tatjana
    Mauricas, Mykolas
    Ivaska, Justinas
    CURRENT STEM CELL RESEARCH & THERAPY, 2017, 12 (01) : 45 - 51
  • [2] REIMBURSEMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S202 - S203
  • [3] Regulating advanced therapy medicinal products through the Hospital Exemption: an analysis of regulatory approaches in nine EU countries
    Coppens, Delphi G. M.
    Gardarsdottir, Helga
    De Bruin, Marie L.
    Meij, Pauline
    Leufkens, Hubert G. M.
    Hoekman, Jarno
    REGENERATIVE MEDICINE, 2020, 15 (08) : 2015 - 2028
  • [4] Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products
    Cuende, Natividad
    Ciccocioppo, Rachele
    Forte, Miguel
    Galipeau, Jacques
    Ikonomou, Laertis
    Levine, Bruce L.
    Srivastava, Alok
    Zettler, Patricia J.
    CYTOTHERAPY, 2022, 24 (07) : 686 - 690
  • [5] Advanced therapy medicinal products: Regulatory framework, hospital and pharmaceutical circuits in Europe and France
    Mebarki, Miryam
    Madelaine, Isabelle
    Larghero, Jerome
    de Jorna, Romain
    THERAPIE, 2022, 77 (02): : 185 - 190
  • [6] Access Challenges of Advanced Therapy Medicinal Products in Europe
    Szulc, E.
    Tschumi, B.
    Pennese, N.
    Lecureuil, C.
    Robbins, S.
    VALUE IN HEALTH, 2022, 25 (12) : S336 - S336
  • [7] THE REIMBURSEMENT STATUS OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2019, 22 : S428 - S428
  • [8] THE REGULATION OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE AND THE ROLE OF ACADEMIA
    Pearce, K. F.
    Hildebrandt, M. O.
    Scheding, S.
    Koehl, U.
    Mischak-Weissinger, E.
    Hauser, A.
    Edinger, M.
    Greinix, H.
    Worel, N.
    Apperley, J.
    Lowdell, M. W.
    Dickinson, A. M.
    CYTOTHERAPY, 2013, 15 (04) : S51 - S52
  • [9] Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective
    Pizevska, Maja
    Kaeda, Jaspal
    Fritsche, Enrico
    Elazaly, Hisham
    Reinke, Petra
    Amini, Leila
    FRONTIERS IN MEDICINE, 2022, 9
  • [10] The regulation of advanced therapy medicinal products in Europe and the role of academia
    Lowdell, M. W.
    Pearce, K. F.
    Apperley, J.
    Dickinson, A. M.
    Edinger, M.
    Greinix, H.
    Hauser, A.
    Koehl, U.
    Mischak-Weissinger, E.
    Scheding, S.
    Worel, N.
    Hildebrandt, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S510 - S510
12345